Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12860 | 814 | 45.0 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3304 | 1346 | SPARC//GROWTH DIFFERENTIATION FACTOR 15//GDF 15 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SPARC | Author keyword | 165 | 54% | 26% | 212 |
2 | OSTEONECTIN | Author keyword | 52 | 45% | 11% | 88 |
3 | BM 40 | Author keyword | 35 | 86% | 2% | 18 |
4 | TESTICAN | Author keyword | 26 | 87% | 2% | 13 |
5 | HEVIN | Author keyword | 23 | 74% | 2% | 17 |
6 | BARBARA JANE LEVY MOL NEUROONCOL | Address | 15 | 71% | 1% | 12 |
7 | ACIDIC AND RICH IN CYSTEINE | Author keyword | 14 | 100% | 1% | 7 |
8 | HOPE HEART PROGRAM | Address | 12 | 29% | 4% | 34 |
9 | SPOCK | Author keyword | 12 | 86% | 1% | 6 |
10 | SPARC OSTEONECTIN BM 40 | Author keyword | 11 | 100% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SPARC | 165 | 54% | 26% | 212 | Search SPARC | Search SPARC |
2 | OSTEONECTIN | 52 | 45% | 11% | 88 | Search OSTEONECTIN | Search OSTEONECTIN |
3 | BM 40 | 35 | 86% | 2% | 18 | Search BM+40 | Search BM+40 |
4 | TESTICAN | 26 | 87% | 2% | 13 | Search TESTICAN | Search TESTICAN |
5 | HEVIN | 23 | 74% | 2% | 17 | Search HEVIN | Search HEVIN |
6 | ACIDIC AND RICH IN CYSTEINE | 14 | 100% | 1% | 7 | Search ACIDIC+AND+RICH+IN+CYSTEINE | Search ACIDIC+AND+RICH+IN+CYSTEINE |
7 | SPOCK | 12 | 86% | 1% | 6 | Search SPOCK | Search SPOCK |
8 | SPARC OSTEONECTIN BM 40 | 11 | 100% | 1% | 6 | Search SPARC+OSTEONECTIN+BM+40 | Search SPARC+OSTEONECTIN+BM+40 |
9 | SPARCL1 | 11 | 78% | 1% | 7 | Search SPARCL1 | Search SPARCL1 |
10 | SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE | 8 | 46% | 2% | 13 | Search SECRETED+PROTEIN+ACIDIC+AND+RICH+IN+CYSTEINE | Search SECRETED+PROTEIN+ACIDIC+AND+RICH+IN+CYSTEINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BINDING PROTEIN SPARC | 76 | 88% | 4% | 36 |
2 | MATRICELLULAR PROTEIN | 72 | 57% | 10% | 85 |
3 | CYSTEINE SPARC | 68 | 80% | 5% | 43 |
4 | OSTEONECTIN | 66 | 43% | 15% | 119 |
5 | SPARC | 60 | 40% | 14% | 118 |
6 | MATRICELLULAR PROTEIN SPARC | 52 | 75% | 5% | 38 |
7 | CA2 BINDING EF HAND | 48 | 100% | 2% | 17 |
8 | HEVIN | 48 | 100% | 2% | 17 |
9 | BM 40 | 44 | 85% | 3% | 23 |
10 | BASEMENT MEMBRANE TUMOR | 32 | 88% | 2% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Stromal expression of SPARC in pancreatic adenocarcinoma | 2013 | 23 | 113 | 76% |
Diverse biological functions of the SPARC family of proteins | 2012 | 37 | 74 | 70% |
Modulation of matrix remodeling by SPARC in neoplastic progression | 2010 | 53 | 140 | 89% |
SPARC, a matricellular protein: at the crossroads of cell-matrix | 2000 | 136 | 84 | 79% |
The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host | 2008 | 69 | 189 | 70% |
SPARC in cancer biology: Its role in cancer progression and potential for therapy | 2008 | 73 | 136 | 66% |
THE BIOLOGY OF SPARC, A PROTEIN THAT MODULATES CELL-MATRIX INTERACTIONS | 1994 | 341 | 82 | 72% |
A prototypic matricellular protein in the tumor | 2008 | 64 | 107 | 70% |
Anti-cancer role of SPARC, an inhibitor of adipogenesis | 2011 | 18 | 114 | 68% |
The regulatory function of SPARC in vascular biology | 2011 | 22 | 71 | 59% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BARBARA JANE LEVY MOL NEUROONCOL | 15 | 71% | 1.5% | 12 |
2 | HOPE HEART PROGRAM | 12 | 29% | 4.2% | 34 |
3 | MED BIOL STRUCT | 2 | 40% | 0.5% | 4 |
4 | HERMELIN BRAIN TUMOR | 2 | 12% | 1.8% | 15 |
5 | WILLIAM KAREN DAVIDSON CELL SIGNALING TUM | 1 | 30% | 0.4% | 3 |
6 | BARRETT ESOPHAGUS UNIT | 1 | 50% | 0.1% | 1 |
7 | BIOL PATHOL MELANOCYTES | 1 | 50% | 0.1% | 1 |
8 | CNRS URA 1188 | 1 | 50% | 0.1% | 1 |
9 | CONTROL FOOD INTAKE GRP | 1 | 50% | 0.1% | 1 |
10 | EXTRACELLULAR MATRIX EML | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000133826 | FSTL1//TMEFF2//TSC 36 |
2 | 0.0000094004 | BONE SIALOPROTEIN//PHOSPHOPHORYN//DENTIN MATRIX PROTEIN 1 |
3 | 0.0000069695 | THROMBOSPONDIN 1//THROMBOSPONDIN//ANGIOCIDIN |
4 | 0.0000057001 | WIG 1//OSTEOACTIVIN//GPNMB |
5 | 0.0000053539 | OSTEOPONTIN//OSTEOPONTIN OPN//OPN |
6 | 0.0000043965 | MARROW FIBROBLASTS//OSTEOPROGENITORS//OSTEOBLASTIC MARKERS |
7 | 0.0000040167 | TENASCIN C//TENASCIN//TENASCIN X |
8 | 0.0000034069 | PERIOSTIN//PERIOSTIN LIKE FACTOR//POSTN |
9 | 0.0000032672 | HSP47//HEAT SHOCK PROTEIN 47//UMB GREENEBAUM CANC |
10 | 0.0000031898 | UKRAIN//CHELIDONIUM//ADJUNCT MEMBER |